Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Allergy. 2012 Mar 28;67(6):813–821. doi: 10.1111/j.1398-9995.2012.02812.x

Figure 1.

Figure 1

Serum baseline total tryptase (sbT) levels detected at patient referral among the different subtypes of mastocytosis in the skin (MIS) (panel A) and among the different groups of MIS established according to the clinical severity of anaphylaxis (panel B). Higher baseline sbT levels were detected in panel A, DCM vs both NM (P < 0.001) and MPCM (P < 0.001), NM vs MPCM (P = 0.02); panel B, grade 4 patients vs all the other groups (P < 0.001).